1-9 of 9
Marija Trajkovic-Arsic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4436: Phenotypic heterogeneity in pancreatic ductal adenocarcinoma revealed by single-cell lipidomics

Marija Trajkovic-Arsic, Jeany Delafiori, Mohammed Shahraz, Corinna Münch, Smiths S. Lueong, Sven T. Liffers, Doris Hellerschmied, Theodore Alexandrov, Jens T. Siveke
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4436.
https://doi.org/10.1158/1538-7445.AM2024-4436
Published: 22 March 2024
View article titled, Abstract 4436: Phenotypic heterogeneity in pancreatic ductal adenocarcinoma revealed by single-cell lipidomics
Journal Articles

Abstract 5019: Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkers

Smiths Sengkwawoh Lueong, Martin Metzenmacher, Gregor Zaun, Gina Lauren Mayer, Erik Jan Hemmer, Katharina Lückerath, Kelsey Pomykala, Balazs Hegedüs, Peter A. Horn, Marija Trajkovic-Arsic, Tibor Szarvas, Renáta Váraljai, Corinna Keup, Ingeborg Tinhofer, Stephen George, Sabine Kasimir-Bauer, Samuel Peña-Llopis, Alexander Roesch, Cornelius Kürten, Lukas Boosfeld, Kirsten Bruderek, Christopher Darr, Thomas Hilser, Viktor Grünwald, Sven Brandau, Boris Hadaschik, Hans Neubauer, Irene Irene Esposito Irene Esposito, Tanja Fehm, Csilla Oláh, Anita Csizmarik, Fabinshy Thangarajah, Laura Reetz, Ghanam Jamal, Basant Kumar Thakur, Halime Kalkavan, Alexander Schramm, Martin Schuler, Jens T. Siveke
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5019.
https://doi.org/10.1158/1538-7445.AM2024-5019
Published: 22 March 2024
View article titled, Abstract 5019: Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkers
Journal Articles

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer

Jörn Weisner, Ina Landel, Christoph Reintjes, Niklas Uhlenbrock, Marija Trajkovic-Arsic, Niklas Dienstbier, Julia Hardick, Swetlana Ladigan, Marius Lindemann, Steven Smith, Lena Quambusch, Rebekka Scheinpflug, Laura Depta, Rajesh Gontla, Anke Unger, Heiko Müller, Matthias Baumann, Carsten Schultz-Fademrecht, Georgia Günther, Abdelouahid Maghnouj, Matthias P. Müller, Michael Pohl, Christian Teschendorf, Heiner Wolters, Richard Viebahn, Andrea Tannapfel, Waldemar Uhl, Jan G. Hengstler, Stephan A. Hahn, Jens T. Siveke, Daniel Rauh
Journal: Cancer Research
Cancer Res (2019) 79 (9): 2367–2378.
https://doi.org/10.1158/0008-5472.CAN-18-2861
Published: 01 May 2019
View article titled, Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <em>KRAS</em>-Mutant Pancreatic and Colorectal Cancer
Open the PDF for Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <em>KRAS</em>-Mutant Pancreatic and Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting

Phyllis F. Cheung, Florian Neff, Christian Neander, Anna Bazarna, Konstantinos Savvatakis, Sven-Thorsten Liffers, Kristina Althoff, Chang-Lung Lee, Everett J. Moding, David G Kirsch, Dieter Saur, Alexandr V. Bazhin, Marija Trajkovic-Arsic, Mathias F. Heikenwalder, Jens T. Siveke
Journal: Cancer Research
Cancer Res (2018) 78 (17): 4997–5010.
https://doi.org/10.1158/0008-5472.CAN-18-0052
Published: 04 September 2018
View article titled, Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting
Open the PDF for Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting in another window
Includes: Supplementary data
Journal Articles

Selective In Vivo Imaging of Syngeneic, Spontaneous, and Xenograft Tumors Using a Novel Tumor Cell–Specific Hsp70 Peptide-Based Probe

Stefan Stangl, Julia Varga, Bianca Freysoldt, Marija Trajkovic-Arsic, Jens T. Siveke, Florian R. Greten, Vasilis Ntziachristos, Gabriele Multhoff
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6903–6912.
https://doi.org/10.1158/0008-5472.CAN-14-0413
Published: 30 November 2014
View article titled, Selective <em>In Vivo</em> Imaging of Syngeneic, Spontaneous, and Xenograft Tumors Using a Novel Tumor Cell–Specific Hsp70 Peptide-Based Probe
Open the PDF for Selective <em>In Vivo</em> Imaging of Syngeneic, Spontaneous, and Xenograft Tumors Using a Novel Tumor Cell–Specific Hsp70 Peptide-Based Probe in another window
Includes: Supplementary data
Journal Articles

Abstract C8: Endogenous mouse models of pancreatic adenocarcinoma as a preclinical trial platform characterized by multiparametric magnetic resonance imaging

Irina Heid, Marija Trajkovic-Arsic, Jens T. Siveke, Rickmer Braren, Manuela Gretzinger, Yvonne Kosanke, Andreas Steingoetter, Sufyan Sayyed, Peter Noel, Bernhard Haller, Ernst J. Rummeny, Roland M. Schmid
Journal: Cancer Research
Cancer Res (2011) 71 (18_Supplement): C8.
https://doi.org/10.1158/1538-7445.FBCR11-C8
Published: 28 October 2014
View article titled, Abstract C8: Endogenous mouse models of pancreatic adenocarcinoma as a preclinical trial platform characterized by multiparametric magnetic resonance imaging
Journal Articles

Abstract C14: Optical imaging of integrin αVβ3 detects pancreatic cancer in endogenous mouse models.

Marija Trajkovic-Arsic, Athanasios Sarantopoulos, George Themelis, Evdokia Kalideris, Rickmer Braren, Vasilis Ntziachristos, Jens Siveke
Journal: Cancer Research
Cancer Res (2011) 71 (18_Supplement): C14.
https://doi.org/10.1158/1538-7445.FBCR11-C14
Published: 28 October 2014
View article titled, Abstract C14: Optical imaging of integrin αVβ3 detects pancreatic cancer in endogenous mouse models.
Journal Articles

Abstract A5: Imaging heterogeneity of endogenous mouse models of pancreatic cancer.

Irina Heid, Marija Trajkovic-Arsic, Irene Esposito, Manuela R. Gretzinger, Andreas Steingoetter, Bernhard Haller, Markus Schwaiger, Ernst J. Rummeny, Jens T. Siveke, Rickmer F. Braren
Journal: Cancer Research
Cancer Res (2012) 72 (14_Supplement): A5.
https://doi.org/10.1158/1538-7445.PANCA2012-A5
Published: 03 April 2014
View article titled, Abstract A5: Imaging heterogeneity of endogenous mouse models of pancreatic cancer.
Journal Articles

Abstract B41: MEK1/2 inhibition with the novel chemotherapeutic agent BAY 86-9766 (RDEA119): A promising treatment strategy for pancreatic cancer.

Nicole Teichmann, Marija Trajkovic-Arsic, Arne Scholz, Schmid M. Roland, Braren Rickmer, Jens T. Siveke
Journal: Cancer Research
Cancer Res (2012) 72 (14_Supplement): B41.
https://doi.org/10.1158/1538-7445.PANCA2012-B41
Published: 03 April 2014
View article titled, Abstract B41: MEK1/2 inhibition with the novel chemotherapeutic agent BAY 86-9766 (RDEA119): A promising treatment strategy for pancreatic cancer.